TrialInternational journal of radiation oncology, biology, physics2023

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.

Daniel E Spratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.